Acne Vulgaris
Pipeline by Development Stage
Drug Modality Breakdown
On Market (8)
Approved therapies currently available
Competitive Landscape
43 companies ranked by most advanced pipeline stage
+13 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 49 trials with date data
Clinical Trials (50)
Total enrollment: 6,375 patients across 50 trials
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation
A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)
Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients
Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients
Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
A Treatment for Severe Inflammatory Acne Subjects
Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars
Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris
Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris
Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel
Effect of Samples on Acne Treatment With Epiduo® Gel
Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel
Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)
A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris
U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™
8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne
U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne
Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.
Dalacin-T Gel Post Approval Study
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin
Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris
Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris
1% Clascoterone Cream for the Treatment Acne Vulgaris
A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
Related Jobs
Chef(fe) de Produits Sevrage Tabagique et dermatologie OTC France - Alternance - H/F
Visitador Médico Pharma Care - Castilla y León
Dermatology Sales Representative - Massachusetts & New Hampshire (Greater Boston)
Dermatology Sales Representative - North & South Carolina (Charlotte)
Immuno-Dermatology - Research Associate -CDI - M/F
Brand Manager Avene
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.